Stanford update:
Yes, the faculty for "specialty clinics" are outstanding: melanoma, lymphoma, rheumderm. And as far a basic science goes, yes, HC is outstanding in the lab (although unless you are in the 2+1 program, this doesn't impact you.)
Unfortunately, along with changes in leadership (new Chair) always comes a "rebuilding phase". That is where Stanford is currently. Most of the seasoned clinicians have departed recently, and there is a noticable void in basic clinical derm currently.
The two stellar pediatric dermatologists are gone, replaced by new graduates.
The MOHS surgeon is gone. Surgery has always been considered a weakness at Stanford, but in reality, without a fellowship, the positive thing was that you always got to do a LOT of surgery, and became very competent. Unfortunately, while the new surgeon is a good didactic teacher, the residents complain that they rarely get to actually do much surgery.
Dermpath has been weak for years, and they just hired two newly graduated faculty. Unfortunately, there is no one "seasoned" in the department, so the referral volume from the community is very low, which hurts dermpath training.
Their "master clinician" who did the lion's share of clinical teaching in the clinics (county hospital) also just retired.
The great new Program Director?: rumor has it he is also leaving to go back to USC.
New inpatient attending? Also just graduated this past year.
While there continues to be a lot of enthusiam within the department, unfortunately the lack of senior attendings in clinical dermatology (outside of specialty clinics) is a definite hit for Stanford. The morale is still there, but curently the senior residents are as smart as many of the new faculty, so a lot of teaching is done resident-to-resident.
Time obviously will heal this weakness, but for now, Stanford can no longer be considered to be in the same category as other top notch programs (unless you want to do basic research) due to its lack of senior clinical faculty.